Project Grant R01GM163225
- Federal Grant Award Summary Duke University's Office of Research Administration received a $807,500 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 1, 2025, with a completion date of February 28, 2030. The award funds a prospective longitudinal cohort study designed to investigate the relationship between gut and blood microbial signatures and immune dysfunction in...
- Federal Grant Award Summary Duke University received a $249,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025 through August 31, 2028. The award supports fundamental research aimed at expanding the catalytic capabilities of enzymes beyond their natural functions to synthesize bioactive pharmaceutical compounds. Specifically, the project engineers heme enzymes and...
- Federal Project Grant Award Summary Duke University received a $482,750 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 1, 2026 through February 28, 2031. The award funds the development of computational methods and workflows to advance single-particle cryo-electron tomography (SP-cryo-ET), a cutting-edge imaging technology for visualizing protein structures within cells...
- Federal Grant Award Summary New York University received a $333,076 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 8, 2025, with a completion date of July 31, 2029. The grant supports the development of novel statistical methods, algorithms, and computational pipelines designed to analyze omics data (genomic, transcriptomic, and connectomics data) while accounting for...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Johns Hopkins University a $426,479 Project Grant effective September 1, 2025 through August 31, 2030 under the Biomedical Research and Research Training program (CFDA 93.859). The award funds development of statistical and computational methods to synthesize genomic and clinical data from biobanks, electronic health records, and clinical registries for precision risk stratification and...
- Federal Grant Award Summary Duke University received a $1,476,308 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 15, 2025, with completion targeted for June 30, 2029. The project delivers a comprehensive research and development initiative to improve intensive care unit (ICU) mortality risk prediction accuracy across diverse patient populations. The award supports development of a...
- Federal Grant Award Summary Duke University received a $737,152 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 10, 2026, with completion anticipated by December 31, 2030. This award consolidates two ongoing NIGMS R01 projects focused on elucidating the structural and mechanistic characterization of metalloenzymes involved in cofactor and natural product biosynthesis....
- Federal Grant Award Summary Duke University's Office of Research Administration received a $807,500 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2025, with completion anticipated by April 30, 2030. The Schmid Lab will conduct integrated experimental and computational systems biology research to characterize the structure, function, and evolution of gene regulatory...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $742,738 Project Grant award from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859) effective May 15, 2025, through February 28, 2030. This Maximizing Investigators' Research Award (MIRA) supports computational research focused on developing and refining methods for accurate computer simulations of enzyme function and biomolecular...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Duke University a Project Grant of $207,617 under the Allergy and Infectious Diseases Research program (CFDA 93.855) beginning September 1, 2025, with completion targeted for August 31, 2030. This award funds a mentoring initiative led by Dr. Sana Syed, MD, MSCR, MSDS to train junior clinical investigators in data science methodologies applied to multi-omic big data analysis. The primary service...
Duke University's Office of Research Administration received a $446,410 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026 through March 31, 2030. The award supports the development and validation of advanced statistical methodologies designed to identify disease subtypes, with specific application to sepsis research. The project delivers three primary products: (1) Bayesian multiview pyramids as an alternative to standard clustering techniques for analyzing heterogeneous patient data; (2) Bayesian multistudy pyramids to enhance reproducibility of disease subtype identification across different clinical studies and patient populations; and (3) robust frameworks for assessing temporal evolution of disease subtypes over time. These statistical tools and methodologies address significant limitations in current clustering approaches, including lack of robustness and poor reproducibility across datasets. The research combines theoretical development, extensive simulation studies, and validation through application to established sepsis cohorts. While the immediate application focuses on sepsis subtyping to facilitate personalized treatment development and improved patient outcomes, the underlying statistical methods are designed for broad applicability across multiple diseases and clinical syndromes where disease endotyping could inform precision medicine approaches. The work is performed at Duke University's Durham, North Carolina facility.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $446.4k | 3/26/26 |